Transcript of Atea Pharmaceuticals, Inc. (AVIR) Earnings Call for Q2 2024
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) had a successful Q2 2024 with strong operational execution and significant clinical progress. The company completed ...
Monday, August 17, 2026
Tag: Atea
Stay updated with DeFi Daily, your trusted source for the latest news, insights, and analysis in finance and cryptocurrency. Explore breaking news, expert analysis, market data, and educational resources to navigate the world of decentralized finance.